Status:

COMPLETED

Behavioral Interventions to Reduce Particulate Matter Exposure in Patients With COPD

Lead Sponsor:

Asan Medical Center

Conditions:

COPD

Eligibility:

All Genders

40-80 years

Phase:

NA

Brief Summary

It is a prospective, multi-institutional clinical study and targets patients diagnosed with chronic obstructive pulmonary disease. About 120 subjects (35 at Ilsan Paik Hospital, 35 at Severance Hospit...

Detailed Description

It is a prospective and multi-institutional clinical study targeting patients with chronic obstructive pulmonary disease in general. A total of 120 COPD patients will be recruited from three institut...

Eligibility Criteria

Inclusion

  • 40 years of age or older
  • Waste function test results show FEV1/FVC\<0.7, FEV1 \<80% of forecast

Exclusion

  • Patients under 18 years of age with changes in medication (such as inhalants).
  • Older people over 80 years of age.
  • People with no respiratory symptoms with mMRC 0.
  • Who doesn't understand a simple explanation for fine dust exposure devices.
  • Someone who disagrees with the study.

Key Trial Info

Start Date :

June 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 31 2023

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT04878367

Start Date

June 1 2021

End Date

March 31 2023

Last Update

April 18 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Asan Medical Center

Seoul, South Korea, 05505

Behavioral Interventions to Reduce Particulate Matter Exposure in Patients With COPD | DecenTrialz